146 related articles for article (PubMed ID: 15047650)
1. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
Levy AP; Friedenberg P; Lotan R; Ouyang P; Tripputi M; Higginson L; Cobb FR; Tardif JC; Bittner V; Howard BV
Diabetes Care; 2004 Apr; 27(4):925-30. PubMed ID: 15047650
[TBL] [Abstract][Full Text] [Related]
2. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
Waters DD; Alderman EL; Hsia J; Howard BV; Cobb FR; Rogers WJ; Ouyang P; Thompson P; Tardif JC; Higginson L; Bittner V; Steffes M; Gordon DJ; Proschan M; Younes N; Verter JI
JAMA; 2002 Nov; 288(19):2432-40. PubMed ID: 12435256
[TBL] [Abstract][Full Text] [Related]
3. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
Patel D; Ahmad S; Silverman A; Lindsay J
Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes.
Weissgerber TL; Gandley RE; Roberts JM; Patterson CC; Holmes VA; Young IS; McCance DR;
BJOG; 2013 Sep; 120(10):1192-9. PubMed ID: 23718253
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population.
Weissgerber TL; Gandley RE; McGee PL; Spong CY; Myatt L; Leveno KJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Samuels P; Sciscione A; Harper M; Tolosa JE; Saade G; Sorokin Y;
PLoS One; 2013; 8(4):e60479. PubMed ID: 23573260
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial.
Kelemen M; Vaidya D; Waters DD; Howard BV; Cobb F; Younes N; Tripputti M; Ouyang P
Atherosclerosis; 2005 Mar; 179(1):193-200. PubMed ID: 15721027
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial.
Fang JC; Kinlay S; Beltrame J; Hikiti H; Wainstein M; Behrendt D; Suh J; Frei B; Mudge GH; Selwyn AP; Ganz P
Lancet; 2002 Mar; 359(9312):1108-13. PubMed ID: 11943259
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
[TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
Costacou T; Levy AP; Miller RG; Snell-Bergeon J; Asleh R; Farbstein D; Fickley CE; Pambianco G; de la Vega R; Evans RW; Orchard TJ
Acta Diabetol; 2016 Apr; 53(2):243-50. PubMed ID: 26002590
[TBL] [Abstract][Full Text] [Related]
10. Vitamins and hormone therapy for coronary atherosclerosis.
Hathcock JN
JAMA; 2003 Feb; 289(8):982; author reply 982. PubMed ID: 12597741
[No Abstract] [Full Text] [Related]
11. Effect of haptoglobin on the metabolism of vitamin C.
Langlois MR; Delanghe JR; De Buyzere ML; Bernard DR; Ouyang J
Am J Clin Nutr; 1997 Sep; 66(3):606-10. PubMed ID: 9280180
[TBL] [Abstract][Full Text] [Related]
12. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.
Hodis HN; Mack WJ; LaBree L; Cashin-Hemphill L; Sevanian A; Johnson R; Azen SP
JAMA; 1995 Jun; 273(23):1849-54. PubMed ID: 7776501
[TBL] [Abstract][Full Text] [Related]
13. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese.
Na N; Delanghe JR; Taes YE; Torck M; Baeyens WR; Ouyang J
Clin Chim Acta; 2006 Mar; 365(1-2):319-24. PubMed ID: 16256097
[TBL] [Abstract][Full Text] [Related]
14. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function.
Kinlay S; Behrendt D; Fang JC; Delagrange D; Morrow J; Witztum JL; Rifai N; Selwyn AP; Creager MA; Ganz P
J Am Coll Cardiol; 2004 Feb; 43(4):629-34. PubMed ID: 14975474
[TBL] [Abstract][Full Text] [Related]
16. Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.
Simpson M; Snell-Bergeon JK; Kinney GL; Lache O; Miller-Lotan R; Anbinder Y; Rewers MJ; Levy AP
Cardiovasc Diabetol; 2011 Nov; 10():99. PubMed ID: 22098782
[TBL] [Abstract][Full Text] [Related]
17. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
[TBL] [Abstract][Full Text] [Related]
18. Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
Nair GV; Waters D; Rogers W; Kowalchuk GJ; Stuckey TD; Herrington DM
Hypertension; 2005 Jan; 45(1):53-7. PubMed ID: 15545509
[TBL] [Abstract][Full Text] [Related]
19. The effects of hormone replacement therapy combined with vitamins C and E on antioxidants levels and lipid profiles in postmenopausal women with Type 2 diabetes.
Naziroğlu M; Simşek M; Simşek H; Aydilek N; Ozcan Z; Atilgan R
Clin Chim Acta; 2004 Jun; 344(1-2):63-71. PubMed ID: 15149872
[TBL] [Abstract][Full Text] [Related]
20. Discordant association of C-reactive protein with clinical events and coronary luminal narrowing in postmenopausal women: data from the Women's Angiographic Vitamin and Estrogen (WAVE) study.
Patel D; Jhamnani S; Ahmad S; Silverman A; Lindsay J
Clin Cardiol; 2013 Sep; 36(9):535-41. PubMed ID: 23754758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
